...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Now that we're a small cap stock....

After BETonMACE top line data release there will be presentation(s) and publication(s) of the full BETonMACE trial data at major conferences and in major journals. Assuming top line is positive, then the full reveal of the detailed outcomes and safety data as well as all of the sub-studies and pre-specified comparisons would offer even more potential headlines/spotlights/catalysts. Top line is only the beginning, if not the end.


New Message
Please login to post a reply